ORPHA:481
Kennedy disease
Also known as: SBMA · SMAX1 · X-linked BSMA · X-linked bulbospinal amyotrophy · X-linked bulbospinal muscular atrophy · X-linked spinal and bulbar muscular atrophy
Publications
3,211
Trials
6
Interventional, condition-specific
Researchers
1,038
Distinct authors in sample
Gene link
AR
Definitive
Readiness
6/6
Stages with a signal
Clinical definition (Orphanet)
Kennedy's disease, also known as bulbospinal muscular atrophy (BSMA), is a rare X-linked motor neuron disease characterized by proximal and bulbar muscle wasting.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0010735
- MeSH:D055534
- OMIM:313200
- UMLS:C1839259
- NCIT:C85233
Additional Mondo synonyms (3)
Kennedy's disease · spinal and bulbar muscular atrophy of Kennedy, X-linked recessive · spinal and bulbar muscular atrophy, X-linked type 1
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
6/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — AR
- LiteraturePresent
3,211 matched papers (2,048 in last 10 years) Source
- Phenotype characterisedPresent
30 HPO annotations (e.g. Dysphagia; Elevated circulating creatine kinase activity; Decreased fertility) Source
- Animal modelPresent
8 genotype models (Mus musculus) Source
- Orphan designationPresent
1 FDA designation (1 FDA orphan-indication approval) — e.g. geranylgeranylacetone Source
- Interventional trialPresent
6 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (AR).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
30
Associated phenotypes · MONDO:0010735
- Dysphagia
- Elevated circulating creatine kinase activity
- Decreased fertility
- Gynecomastia
- Fasciculations
Showing 5 of 30 — open Monarch for the full list.
Animal models (Monarch / Alliance)
8
Model associations linked to this Mondo ID
- Artm4(AR)Dmr/Y [background:] involves: 129S1/Sv * C57BL/6J·MGI:3614453·Mus musculus
- Tg(Prnp-AR*112Q)#Deme/0 [background:] involves: C57BL/6 * SJL·MGI:5308127·Mus musculus
- Tg(AR*100Q)#Als/0 [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J·MGI:5000281·Mus musculus
- Tg(AR*100Q)C25Als/0 [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J·MGI:5000279·Mus musculus
- Tg(ACTA1-Ar)141Kyjo/0 [background:] Not Specified·MGI:3794207·Mus musculus
- Tg(CAG-AR*97Q)7-8Sobue/? [background:] involves: C57BL/6 * C57BL/6J * DBA/2·MGI:3767789·Mus musculus
- Tg(AR*100Q)C32Als/0 [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J·MGI:5000280·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
1
Designation · 1 with FDA orphan-indication approval
- FDA geranylgeranylacetoneSpinal and Bulbar Muscular Atrophy · 2020-06-26 · Not FDA Approved for Orphan Indication
Sources: FDA OOPD · EMA orphan designations
Open Targets candidates
5
Drugs / clinical candidates · MONDO_0010735
- CLENBUTEROL·phase 2
- DUTASTERIDE·phase 2
- LEUPROLIDE ACETATE·phase 2
- TESTOSTERONE ENANTHATE·phase 2
- MEXILETINE HYDROCHLORIDE·phase 2 3
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
3,211
3,211 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
3,211 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
2,048 in the last 10 years · low confidence
Phrase hits: 1,579 · MeSH hits: 0
Who's working on it?
1,038
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Gutjahr C10 papers · 2026
Plant Genetics, TUM School of Life Sciences, Technical University of Munich (TUM), Emil Ramann Str. 4, 85354, Freising, Germany.
Papers in Europe PMC - 02Nelson DC10 papers · 2025
Department of Botany and Plant Sciences, University of California, Riverside, CA 92521, USA.
Papers in Europe PMC - 03Wang Y8 papers · 2026
Prenatal Diagnostic Center of Obstetrics and Department of Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Papers in Europe PMC - 04La Spada AR6 papers · 2025
Department of Neurology, Duke University School of Medicine; Duke Center for Neurodegeneration & Neurotherapeutics, Duke University School of Medicine; Department of Neurobiology, Duke University School of Medicine; Department of Cell Biology, Duke University School of Medicine.
Papers in Europe PMC - 05Liu Y6 papers · 2026
Department of Neurology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
Papers in Europe PMC - 06Seto Y6 papers · 2026
Laboratory of Plant Chemical Regulation, School of Agriculture, Meiji University, 1-1-1, Higashi-mita, Tama-ku, Kawasaki 214-8571 Japan.
Papers in Europe PMC - 07Yang X6 papers · 2026
Department of Neurology, Changchun Central Hospital, Changchun 130000, China.
Papers in Europe PMC - 08Zhang Y6 papers · 2026
State Key Laboratory of Elemento-Organic Chemistry and Department of Chemical Biology, National Pesticide Engineering Research Center, Collaborative Innovation Center of Chemical Science and Engineering, College of Chemistry, Nankai University, 300071, Tianjin, P. R. China.
Papers in Europe PMC - 09Chang SH5 papers · 2026
Department of Botany and Plant Sciences, University of California, Riverside, California 92521.
Papers in Europe PMC - 10Li Q5 papers · 2024
Department of Botany and Plant Sciences, University of California, Riverside, California 92521.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
6
interventional trials for this specific condition
6 interventional trials matched this specific condition name; none in our sample are currently recruiting.
Data as of 11 September 2026 · last trial check 28 July 2026
6 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 90.1th percentile).
low confidence · 90.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
6 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Observational and natural-history studies
3 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT05966038·RECRUITING·ALS/MND Natural History Study Data Repository
Not reviewed·Conditions: ALS · PLS · MND (Motor Neurone DIsease) · Kennedy Disease·Matched via name phrase
General rare disease registries you may be eligible for
These studies enroll across many rare conditions. They are not counted as evidence that anyone is studying this specific disease.
- NCT01793168·RECRUITING·Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Not reviewed·Conditions: Rare Disorders · Undiagnosed Disorders · Disorders of Unknown Prevalence · Cornelia De Lange Syndrome
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 40 · after dedupe 40 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 40 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (40)
- isrctn·ISRCTN77379187·No longer recruiting·Nurse-led palliative care intervention for heart failure patients in Uganda
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN34699816·No longer recruiting·Understanding speech-related breathing behaviours in age-related voice disorder
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14012649·Recruiting·PRX-102 in children and adolescents with Fabry disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN64997989·No longer recruiting·General practice study about chest infections in adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14149329·No longer recruiting·APPROACH: a mobile phone app to encourage increased health & wellbeing after cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN61613198·No longer recruiting·The ketogenic diet in bipolar disorder
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16717773·No longer recruiting·A proof of concept study to test whether talarozole has an effect on hand osteoarthritis in the base of thumb joint
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN38930336·No longer recruiting·Evaluation of a COVID-19 lateral flow self-test: What is the performance of the Panbio™ COVID-19 self-test device when performed by lay users?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN27075727·Stopped·The Anti-Freaze-F Study - "Anti-TNF for treatment of frozen shoulder" - a feasibility study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15634328·No longer recruiting·Coronavirus (COVID-19) antibody response in healthcare staff: What proportion of healthcare staff have COVID-19 antibodies? How long do the antibodies last? Do the antibodies protect against recurring infection?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN57632435·No longer recruiting·Severity of sleep apnoea in chronic obstructive pulmonary disease patients who require non-invasive mechanical ventilation with pressure support guaranteed with average volume
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN80204146·No longer recruiting·DPACT dementia support study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17904857·No longer recruiting·Comparing ventilation strategies for patients with de novo hypoxemic respiratory failure
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12196200·No longer recruiting·Can we use estrogen-containing therapy to improve pain in women after menopause with hand osteoarthritis? (HOPE-e study)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN31852047·No longer recruiting·Randomised feasibility trial of an onward HIV disclosure intervention
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN36962030·No longer recruiting·Defining best management in adult chronic rhinosinusitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17503205·No longer recruiting·Stopping Eculizumab Treatment Safely in atypical Haemolytic Uraemic Syndrome (SETS aHUS)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10327305·No longer recruiting·Primary care management of lower urinary tract symptoms in men
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13036391·No longer recruiting·Use of non-invasive mechanical ventilation with pressure support guaranteed with average volume (AVAPS) in de novo hypoxemic respiratory failure
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN96455367·No longer recruiting·AVAPS in Acute Respiratory Failure of various etiologies
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN79432558·No longer recruiting·Cold air, physical activity and the airways
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16751129·No longer recruiting·Capsaicinoids effect on appetite response
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN84856452·No longer recruiting·Mechanistic and efficacy studies on a tomato extract with antiplatelet properties
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN69614598·No longer recruiting·SUMS: Standing up in people with multiple sclerosis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN27786905·No longer recruiting·Repurposing anti-TNF for treating Dupuytren’s disease
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Kennedy disease — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Kennedy disease" OR "SMAX1" OR "X-linked BSMA" OR "X-linked bulbospinal amyotrophy" OR "X-linked bulbospinal muscular atrophy" OR "X-linked spinal and bulbar muscular atrophy" OR "Kennedy's disease" OR "spinal and bulbar muscular atrophy of Kennedy, X-linked recessive" OR "spinal and bulbar muscular atrophy of the Kennedy, X-linked recessive" OR "spinal and bulbar muscular atrophy, X-linked type 1") OR ("AR syndrome" OR "AR-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Kennedy disease" OR "SMAX1" OR "X-linked BSMA" OR "X-linked bulbospinal amyotrophy" OR "X-linked bulbospinal muscular atrophy" OR "X-linked spinal and bulbar muscular atrophy" OR "Kennedy's disease" OR "spinal and bulbar muscular atrophy of Kennedy, X-linked recessive" OR "spinal and bulbar muscular atrophy of the Kennedy, X-linked recessive" OR "spinal and bulbar muscular atrophy, X-linked type 1"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 6 interventional · 3 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: SBMA
Confidence reasoning
- Preferred label is short or not clearly distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (3211) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-26T13:59:03.672Z
